Skip to main content

Filter content

January 22, 2021
Methamphetamine overdose deaths soared across the U.S. from 2011-18, with American Indians and Alaska Natives registering the highest death rates overall, according to a study conducted at the National Institute on Drug Abuse.
PODCAST
January 22, 2021
In this podcast, Esme Fuller-Thomson, PhD, discusses her recent research which showed significantly higher rates of suicide attempt and ideation among people with attention-deficit/hyperactivity disorder (ADHD).
January 21, 2021
Long-acting injectable (LAI) paliperidone palmitate significantly improved outcomes in patients with schizophrenia despite duration of illness, but those with shorter illness duration showed the best improvement, a study found.
January 21, 2021
Research studies that will investigate perinatal depression in women and possible new treatments for it will be led by Kristina Deligiannidis, MD, of the Feinstein Institutes' Institute of Behavioral Science, Glen Oaks, New York.
January 21, 2021
The protein transthyretin (TTR) may play a role in the development of new treatments for Alzheimer’s disease by preventing the formation of amyloid beta clumps, according to study.
January 21, 2021
In this video, Leslie Citrome, MD, MPH, discusses the use of long-acting injectable antipsychotics in the treatment of schizophrenia and bipolar disorder.
January 21, 2021
atai Life Sciences, a clinical-stage biopharmaceutical firm backed by Peter Thiel and other investors, recently acquired a majority stake in Recognify Life Sciences. Recognify is developing a treatment for cognitive impairment associated with schizophrenia (CIAS). Its lead compound has…
PSYCHHUB360
January 20, 2021
Having less access to nature during lockdowns early in the COVID-19 pandemic was associated with reported symptoms of depression and anxiety, researchers reported in the journal Science of the Total Environment.
January 20, 2021
The proposal by Philadelphia not-for-profit Safehouse to open the first supervised injection facility in the United States has hit a roadblock after a U.S. Circuit Court of Appeals ruled, 2-1, that doing so would violate federal law.
January 20, 2021
Psychedelic medicine biotech firm MindMed has announced the launch of a clinical trial that will evaluate the use of MDMA and LSD in combination. The trial will look to determine whether MDMA can increase positive subject drug effects and reduce negative emotions and anxiety that are sometimes…
Back to Top